AQR Capital Management
JANX icon

AQR Capital Management’s Janux Therapeutics JANX Stock Holding History

AQR Capital Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
+108,077
New +$1.57M ﹤0.01% 2728
2025
Q2 		– Sell
-9,717
Closed -$262K – 3336
2025
Q1 		$262K Buy
9,717
+4,059
+72% +$153K ﹤0.01% 2748
2024
Q4 		$303K Buy
5,658
+134
+2% +$7.09K ﹤0.01% 2484
2024
Q3 		$251K Buy
5,524
+399
+8% +$17.4K ﹤0.01% 2482
2024
Q2 		$215K Buy
+5,125
New +$241K ﹤0.01% 2397

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

AQR Capital Management's JANX Position: Q2 2026 in Review

AQR Capital Management opened a new position in Janux Therapeutics (JANX) in Q2 2026: 108,077 shares worth $1.66M. The stake represents ﹤0.01% of the portfolio and ranks #2728 among its holdings. This is a return to the name: AQR Capital Management previously reported a position in JANX as recently as Q1 2025.

AQR Capital Management first reported a position in JANX in Q2 2024 and has held it in 5 quarters since. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • AQR Capital Management held 108,077 shares of Janux Therapeutics worth $1.66M as of Q2 2026.
  • Janux Therapeutics was a new AQR Capital Management position in Q2 2026.
  • Janux Therapeutics made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #2728 holding.
  • AQR Capital Management first reported a position in Janux Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.